Unknown

Dataset Information

0

Effect of sialylation on EGFR phosphorylation and resistance to tyrosine kinase inhibition.


ABSTRACT: Epidermal growth factor receptor (EGFR) is a heavily glycosylated transmembrane receptor tyrosine kinase. Upon EGF-binding, EGFR undergoes conformational changes to dimerize, resulting in kinase activation and autophosphorylation and downstream signaling. Tyrosine kinase inhibitors (TKIs) have been used to treat lung cancer by inhibiting EGFR phosphorylation. Previously, we demonstrated that EGFR sialylation suppresses its dimerization and phosphorylation. In this report, we further investigated the effect of sialylation on the phosphorylation profile of EGFR in TKI-sensitive and TKI-resistant cells. Sialylation was induced in cancer progression to inhibit the association of EGFR with EGF and the subsequent autophosphorylation. In the absence of EGF the TKI-resistant EGFR mutant (L858R/T790M) had a higher degree of sialylation and phosphorylation at Y1068, Y1086, and Y1173 than the TKI-sensitive EGFR. In addition, although sialylation in the TKI-resistant mutants suppresses EGFR tyrosine phosphorylation, with the most significant effect on the Y1173 site, the sialylation effect is not strong enough to stop cancer progression by inhibiting the phosphorylation of these three sites. These findings were supported further by the observation that the L858R/T790M EGFR mutant, when treated with sialidase or sialyltransferase inhibitor, showed an increase in tyrosine phosphorylation, and the sensitivity of the corresponding resistant lung cancer cells to gefitinib was reduced by desialylation and was enhanced by sialylation.

SUBMITTER: Yen HY 

PROVIDER: S-EPMC4460513 | biostudies-literature | 2015 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Effect of sialylation on EGFR phosphorylation and resistance to tyrosine kinase inhibition.

Yen Hsin-Yung HY   Liu Ying-Chih YC   Chen Nai-Yu NY   Tsai Chia-Feng CF   Wang Yi-Ting YT   Chen Yu-Ju YJ   Hsu Tsui-Ling TL   Yang Pan-Chyr PC   Wong Chi-Huey CH  

Proceedings of the National Academy of Sciences of the United States of America 20150513 22


Epidermal growth factor receptor (EGFR) is a heavily glycosylated transmembrane receptor tyrosine kinase. Upon EGF-binding, EGFR undergoes conformational changes to dimerize, resulting in kinase activation and autophosphorylation and downstream signaling. Tyrosine kinase inhibitors (TKIs) have been used to treat lung cancer by inhibiting EGFR phosphorylation. Previously, we demonstrated that EGFR sialylation suppresses its dimerization and phosphorylation. In this report, we further investigated  ...[more]

Similar Datasets

| S-EPMC6125176 | biostudies-literature
| S-EPMC6994195 | biostudies-literature
| S-EPMC4548796 | biostudies-literature
2021-05-04 | GSE168043 | GEO
| S-EPMC8316404 | biostudies-literature
| S-EPMC3542232 | biostudies-literature
| S-EPMC7611293 | biostudies-literature
| S-EPMC3139833 | biostudies-literature
| S-EPMC5739624 | biostudies-literature
| S-EPMC4950506 | biostudies-literature